| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.50B | +4.5% |
| Cost of Revenue | $390.7M | +3.2% |
| Gross Profit | $1.11B | +5.0% |
| R&D Expense | $298.1M | +0.9% |
| SG&A Expense | $112.8M | +16.6% |
| Operating Income | $123.9M | +53.0% |
| Pre-tax Income | $142.6M | +49.5% |
| Income Tax | $43.4M | +57.2% |
| Net Income | $99.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $337.1M | +46.6% |
| Short-term Investments | $402.9M | +108.3% |
| Accounts Receivable | $305.5M | +1.8% |
| Current Assets | $1.33B | +29.6% |
| Total Assets | $1.77B | +17.0% |
| Current Liabilities | $1.09B | +88.2% |
| Total Liabilities | $1.18B | +2.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $345.9M | +58.8% |
| Capital Expenditures | $7.7M | -54.0% |
| Investing Cash Flow | -$202.6M | -299.2% |
| Financing Cash Flow | -$30.2M | +63.1% |
| Free Cash Flow | $338.2M | +68.3% |
| +46.3% |
| EPS (Basic) | $1.16 | +41.5% |
| EPS (Diluted) | $1.11 | +52.1% |
| Stockholders' Equity |
| $585.5M |
| +65.5% |